Stocktoria

MIRA PHARMACEUTICALS, INC. MIRA

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2023-08-03 · LEI

MIRA PHARMACEUTICALS, INC. statistics & valuation

Market cap$42.4M
P / B4.1×
Return on equity-100.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2022202320242025
Operating margin (%)
2022202320242025
Return on equity (%)
-273.90% -357.00% -100.50% 2022202320242025
Shares outstanding
17.6M 14.8M 16.6M 41.9M 2022202320242025
Net debt ($)
2022202320242025
Share buybacks ($)
2022202320242025
Return on assets (%)
-822.60% -242.90% -268.60% -94.10% 2022202320242025
Free cash flow margin (%)
2022202320242025
Debt / equity (×)
2022202320242025
EPS ($)
-$0.40 -$0.85 -$0.51 -$1.35 2022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022
Return on assets-94.1%-268.6%-242.9%-822.6%
Return on equity-100.5%-357.0%-273.9%1183.8%
Current ratio15.753.998.700.36

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.